Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Indicators02:39

Indicators

Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are called...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of a care pathway with systematical screening for cardiopulmonary complications, frailty, malnutrition and minimal hepatic encephalopathy in cirrhosis on patient care and hospital financing.

Acta gastro-enterologica Belgica·2026
Same author

Patient-perceived barriers and facilitators for risk-stratified follow-up care in lung cancer: a qualitative study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Creating a prediction model for invasive candidiasis in the intensive care unit using a case control design: a European multicentre approach.

BMC infectious diseases·2025
Same author

Nerve entry points in the mimic musculature of the horse head.

Anatomia, histologia, embryologia·2024
Same author

[Hardnekkige aanhoudende lichamelijke klachten in de huisartsenpraktijk].

Tijdschrift voor psychiatrie·2024
Same author

Acute grade IV toxic hepatitis due to the e-cigarette.

Acta gastro-enterologica Belgica·2024

Related Experiment Video

Updated: Jul 17, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Clinical indicators: development and applications.

H Wollersheim1, R Hermens, M Hulscher

  • 1Centre for Quality of Care Research (WOK 117), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, the Netherlands.

The Netherlands Journal of Medicine
|February 13, 2007
PubMed
Summary

Developing high-quality clinical indicators is crucial for assessing patient care. These indicators must be valid, reliable, and transparently constructed to drive quality improvement initiatives.

Related Experiment Videos

Last Updated: Jul 17, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Area of Science:

  • Healthcare Quality Improvement
  • Clinical Effectiveness Research
  • Health Services Research

Background:

  • Clinical indicators are essential for evaluating patient care quality.
  • High standards, careful construction, and transparency are necessary for indicator development.
  • Indicators must align with evidence-based recommendations concerning clinical effectiveness, safety, and efficiency.

Purpose of the Study:

  • To outline the principles and methodologies for developing robust clinical indicators.
  • To emphasize the importance of validity, reliability, and feasibility in indicator selection.
  • To demonstrate the application of clinical indicators in quality improvement strategies.

Main Methods:

  • Indicators are selected based on research data, evidence-based guidelines, and expert opinion.
  • Key selection criteria include relevance, validity, reliability, measurability, and improvability.
  • Development involves precise definition, try-outs, measurement, and in-depth analysis of results, including case-mix correction.

Main Results:

  • The study provides a framework for developing and applying clinical indicators.
  • Examples illustrate indicator development in oncology, diabetes care, and pneumonia antibiotic use.
  • Comparison with reference data is highlighted as a tool for constructing improvement programs.

Conclusions:

  • Well-developed clinical indicators are vital for monitoring and improving healthcare quality.
  • A systematic approach ensures indicators are valid, reliable, and actionable.
  • The application of indicators, coupled with feedback and improvement strategies, enhances patient care outcomes.